Loading ticker data...
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| 2026-01-02 | Burns Kristie | Sr. VP Mktg & Clinical Affairs | Sell | 5,139 | $28.85 | $148,260.15 | -6.6% | → |
| 2025-08-08 | Dodd Sheri Louise | Chief Executive Officer | Sell | 7,762 | $12.36 | $95,907.27 | -4.3% | → |
| 2025-05-12 | Birkemeyer Elaine M. | Chief Financial Officer | Sell | 2,921 | $9.94 | $29,037.37 | -2.9% | → |
| 2025-05-08 | Dodd Sheri Louise | Chief Executive Officer | Sell | 3,149 | $9.83 | $30,954.67 | -1.7% | → |
| 2025-05-08 | BURKE WILLIAM W | Director | Sell | 3,300 | $9.67 | $31,911.00 | -6.4% | → |
| 2025-02-25 | Birkemeyer Elaine M. | Chief Financial Officer | Sell | 2,066 | $14.51 | $29,979.52 | -2.0% | → |
| 2025-02-25 | REUVERS DANIEL L. | Director | Sell | 28,338 | $14.18 | $401,849.84 | -11.7% | → |
| 2025-02-25 | Burns Kristie | Sr. VP Mktg & Clinical Affairs | Sell | 6,468 | $14.40 | $93,159.90 | -7.7% | → |
| 2025-02-24 | REUVERS DANIEL L. | Director | Sell | 10,938 | $14.55 | $159,146.81 | -4.3% | → |
| 2025-02-24 | Birkemeyer Elaine M. | Chief Financial Officer | Sell | 3,778 | $14.70 | $55,538.11 | -3.5% | → |
| 2025-02-24 | Burns Kristie | Sr. VP Mktg & Clinical Affairs | Sell | 4,830 | $14.65 | $70,752.74 | -5.4% | → |
| 2024-08-12 | Ferstler Sherri Lee | Senior VP, Sales | Sell | 1,550 | $13.07 | $20,262.53 | -3.8% | → |
| 2024-05-16 | Birkemeyer Elaine M. | Chief Financial Officer | Sell | 3,041 | $13.68 | $41,589.63 | -4.7% | → |
| 2024-05-08 | BURKE WILLIAM W | Director | Sell | 2,500 | $14.06 | $35,150.00 | -9.0% | → |
| 2024-05-06 | Burns Kristie | Sr. VP Mktg & Clinical Affairs | Sell | 815 | $14.37 | $11,712.77 | -1.3% | → |
| 2024-02-29 | REUVERS DANIEL L. | President and CEO | Sell | 6,085 | $15.52 | $94,437.40 | -1.3% | → |
| 2024-02-29 | Burns Kristie | Sr. VP Mktg & Clinical Affairs | Sell | 1,334 | $15.52 | $20,707.03 | -1.0% | → |
| 2024-02-26 | Burns Kristie | Sr. VP Mktg & Clinical Affairs | Sell | 4,264 | $15.32 | $65,326.58 | -3.5% | → |
| 2024-02-26 | REUVERS DANIEL L. | President and CEO | Sell | 11,617 | $15.37 | $178,497.37 | -2.6% | → |
| 2023-08-07 | REUVERS DANIEL L. | President and CEO | Sell | 1,062 | $20.53 | $21,807.64 | -0.8% | → |
| 2023-05-12 | BURKE WILLIAM W | Director | Sell | 4,400 | $21.86 | $96,184.00 | -13.7% | → |
| 2023-05-08 | Burns Kristie | Sr. VP Mktg & Clinical Affairs | Sell | 786 | $18.65 | $14,658.98 | -2.1% | → |
| 2023-05-08 | PAULS ERIC | Senior VP, Sales | Sell | 550 | $18.55 | $10,199.92 | -1.8% | → |
| 2023-03-01 | Moen Brent | Chief Financial Officer | Sell | 1,391 | $14.10 | $19,613.10 | -2.8% | → |
| 2023-02-28 | Burns Kristie | Sr. VP Mktg & Clinical Affairs | Sell | 2,297 | $15.34 | $35,243.86 | -3.0% | → |
| 2023-02-28 | Moen Brent | Chief Financial Officer | Sell | 4,052 | $15.32 | $62,058.85 | -3.9% | → |
| 2023-02-28 | PAULS ERIC | Senior VP, Sales | Sell | 1,473 | $15.29 | $22,524.16 | -2.4% | → |
| 2023-02-28 | REUVERS DANIEL L. | President and CEO | Sell | 7,087 | $15.20 | $107,721.67 | -2.7% | → |
| 2022-08-08 | REUVERS DANIEL L. | President and CEO | Sell | 1,020 | $9.18 | $9,363.70 | -1.3% | → |
| 2022-08-04 | BURKE WILLIAM W | Director | Buy | 4,900 | $9.15 | $44,835.00 | +25.1% | → |
| 2022-05-19 | BURKE WILLIAM W | Director | Sell | 1,100 | $10.12 | $11,132.00 | -5.3% | → |
| 2022-05-06 | Burns Kristie | Sr. VP Mktg & Clinical Affairs | Sell | 999 | $13.04 | $13,022.56 | -4.4% | → |
| 2022-05-06 | PAULS ERIC | Senior VP, Sales | Sell | 600 | $13.03 | $7,819.08 | -3.2% | → |
| 2022-03-07 | Moen Brent | Chief Financial Officer | Sell | 176 | $20.64 | $3,633.06 | -0.3% | → |
| 2022-03-01 | Moen Brent | Chief Financial Officer | Sell | 1,632 | $20.33 | $33,179.38 | -3.0% | → |
| 2022-02-28 | Moen Brent | Chief Financial Officer | Sell | 624 | $19.85 | $12,383.28 | -1.1% | → |
| 2022-02-28 | REUVERS DANIEL L. | President and CEO | Sell | 877 | $19.78 | $17,350.39 | -1.1% | → |
| 2021-08-06 | REUVERS DANIEL L. | President and CEO | Sell | 1,063 | $43.11 | $45,828.16 | -4.5% | → |
| 2021-07-07 | REUVERS DANIEL L. | President and CEO | Sell | 2,961 | $49.75 | $147,319.82 | -11.1% | → |
| 2021-06-24 | BURKE WILLIAM W | Director | Sale+OE | 6,761 | $55.00 | $371,855.00 | -44.2% | → |
| 2021-05-13 | BURKE WILLIAM W | Director | Sell | 800 | $52.08 | $41,664.00 | -13.7% | → |
| 2021-03-05 | Rishe Bryan | SVP, Sales | Sell | 196 | $47.15 | $9,241.79 | -0.5% | → |